# Degron Therapeutics

**Source:** https://www.startuphub.ai/startups/degron-therapeutics
**Profile type:** Startup

> Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

## About

Degron Therapeutics develops novel molecular glue degrader (MGD) drugs using its proprietary GlueXplorer® platform to target historically intractable disease targets. This platform leverages a large, structurally differentiated compound library and advanced screening systems to address the challenges of rational MGD design. The company aims to "drug the undruggable" by creating new therapeutic options for diseases.

## Key facts

- **Slug:** degron-therapeutics
- **Website:** https://degrontx.com/
- **Location:** San Diego, California, USA
- **Founded:** 2020-01-01
- **Employees:** 24
- **Operating status:** Active
- **Total funding:** $40M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare, Biotech, Clinical Trials, HealthTech, Molecular Glue Degraders, Oncology, Neuroscience
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/degrontx/

## Frequently asked

### What does Degron Therapeutics do?

Degron Therapeutics develops novel molecular glue degrader (MGD) drugs using its proprietary GlueXplorer® platform to target historically intractable disease targets. This platform leverages a large, structurally differentiated compound library and advanced screening systems to address the challenges of rational MGD design. The company aims to "drug the undruggable" by creating new therapeutic options for diseases. (formerly [].)

### What is Degron Therapeutics's revenue?

StartupHub estimates Degron Therapeutics's annual revenue at $2.6M (range $1.4M to $8.5M, 69% confidence), based on comparable companies in the sector.

### What is Degron Therapeutics's valuation?

StartupHub estimates Degron Therapeutics's effective valuation at $1.1B (range $790.6M to $1.5B, 42% confidence), based on comparable companies in the sector.

### How much funding has Degron Therapeutics raised?

Degron Therapeutics has raised a total of $40M in funding. The most recent round on record is Series A Extension.

### Where is Degron Therapeutics headquartered?

Degron Therapeutics is headquartered in San Diego, California, USA.

### When was Degron Therapeutics founded?

Degron Therapeutics was founded in 2020.

### What industry does Degron Therapeutics operate in?

Degron Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare, Biotech, Clinical Trials.

### How many employees does Degron Therapeutics have?

Degron Therapeutics has approximately 24 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Degron Therapeutics",
          "item": "https://www.startuphub.ai/startups/degron-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/degron-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/degron-therapeutics",
      "name": "Degron Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Degron Therapeutics (formerly []). Degron Therapeutics is a startup founded in 2020, operating in Biotechnology and Pharmaceuticals. Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. Headquartered in San Diego, California, USA. The company has approximately 24 employees.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/degron-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/degron-therapeutics#organization",
      "name": "Degron Therapeutics",
      "url": "https://degrontx.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/0f647d4c-7462-4fdd-82f7-3226956b1d7f-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/0f647d4c-7462-4fdd-82f7-3226956b1d7f-square.webp",
      "description": "This is the official profile of Degron Therapeutics (formerly []). Degron Therapeutics is a startup founded in 2020, operating in Biotechnology and Pharmaceuticals. Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. Headquartered in San Diego, California, USA. The company has approximately 24 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/degrontx/",
        "https://www.startuphub.ai/startups/degron-therapeutics"
      ],
      "foundingDate": "2020-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 24
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "San Diego",
        "addressRegion": "California",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Drug Discovery",
        "Healthcare",
        "Biotech",
        "Clinical Trials",
        "HealthTech",
        "Molecular Glue Degraders",
        "Oncology",
        "Neuroscience"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/degron-therapeutics#profile-assessment",
      "name": "Degron Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/degron-therapeutics",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/0f647d4c-7462-4fdd-82f7-3226956b1d7f-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of Degron Therapeutics (formerly []). Degron Therapeutics is a startup founded in 2020, operating in Biotechnology and Pharmaceuticals. Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. Headquartered in San Diego, California, USA. The company has approximately 24 employees. Agent Readiness score: 27/100. Full audit: https://www.startuphub.ai/startups/degron-therapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Degron Therapeutics"
      }
    }
  ]
}
```